Naprosyn®

DRUG3 trials

Sponsors

Logical Therapeutics, Oxford Pharmascience Ltd

Conditions

HealthyOsteoarthritisPharmacokinetics

Phase 1

Comparator Study of LT-NS001 in Healthy Subjects With Endoscopic Evaluation

CompletedNCT00750243

Logical TherapeuticsHealthy

Start: 2008-09-30End: 2009-04-30Updated: 2010-10-06

Phase I Study PK Study With OXP005 and Naprosyn

CompletedNCT02351024

Oxford Pharmascience LtdPharmacokinetics

Start: 2015-02-28End: 2015-03-31Updated: 2015-04-01

Phase 2

Rates of Gastric Ulcer by Endoscopy in Knee Osteoarthritis Patients Receiving LT-NS001 Versus Naprosyn®

CompletedNCT01063920

Logical TherapeuticsOsteoarthritis

Start: 2010-02-28End: 2010-11-30Target: 534Updated: 2011-01-24

Related Papers

Clinical trial: endoscopic evaluation of naproxen etemesil, a naproxen prodrug, vs. naproxen - a proof-of-concept, randomized, double-blind, active-comparator study.

2010-08-237 citations